Electrical Storm as an Independent Mortality Risk in Patients with Preserved or Moderately Reduced Left Ventricular Function

Int Heart J. 2021 Nov 30;62(6):1249-1256. doi: 10.1536/ihj.20-832. Epub 2021 Nov 17.

Abstract

Electrical storm (ES), defined by 3 or more occurrences of ventricular arrhythmias within 24 hours, has been shown to be associated with an increased risk of mortality; however, detailed information remains lacking. We aimed to examine the incidence and determinants of ES and its impact on mortality in patients enrolled in the nationwide implantable cardioverter-defibrillator (ICD) registry.We studied 1,256 patients (age 65 ± 12 years) who had structural heart disease with an ICD. The patients were classified into reduced ejection fraction (EF < 35%; 657 (52%) patients) and preserved or moderately reduced EF (EF ≥ 35%; 599 (48%) patients).ES occurred in 49 (7%) and 36 (6%) patients in the EF < 35% and EF ≥ 35% groups (log-rank P = 0.297) during the median follow-up of 2.3 years. ICD with resynchronization therapy was associated with a lower incidence of ES in patients with EF < 35%. Non-ischemic heart disease and diuretics were associated with ES in patients with EF ≥ 35%. During the follow-up, 10/49 (20%) patients with ES and 80/608 patients (13%) without ES died in patients with EF < 35%, while 7/36 (19%) patients with ES and 38/563 patients (7%) without ES died in those with EF ≥ 35%. We have created 4 Cox multivariate models. All models showed approximately 2-fold higher hazard ratios in patients with EF ≥ 35% compared to EF < 35%.Our study showed that the determinants of ES differed between EF < 35% and EF ≥ 35%. The impact of ES for mortality was numerically higher in EF ≥ 35% than in EF < 35%, although a significant interaction was not detected.

Keywords: Implantable cardioverter-defibrillator; Mortality; Non-ischemic heart disease; Ventricular tachycardia.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Aged
  • Cardiac Resynchronization Therapy
  • Defibrillators, Implantable*
  • Diuretics / therapeutic use
  • Female
  • Heart Diseases / mortality
  • Heart Diseases / therapy
  • Humans
  • Japan / epidemiology
  • Male
  • Multivariate Analysis
  • Prognosis
  • Prospective Studies
  • Registries
  • Stroke Volume / physiology*
  • Tachycardia, Ventricular / mortality*
  • Tachycardia, Ventricular / physiopathology*

Substances

  • Diuretics